Re: Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes.
- From: "GysdeJongh" <jongh711@xxxxxxxxx>
- Date: Mon, 1 Aug 2005 22:24:08 +0200
"palm" <palm650@xxxxxxxxx> wrote in message
news:1122916369.640397.226670@xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
> Studies after studies, after studies, after studies prove that
> frequency of blood sugar testing, in Type 2 diabetics, who do not use
> insulin, have no relation to blood glucose control:
Hi palm,
this is a very good one :
Study done in Italy,involve two thousand diabetics, over three years.
Conclusion: "In a large sample of non-insulin-treated Type 2 diabetic
patients, the performance and frequency of SMBG did not predict better
metabolic control over 3 years." Published in July of 2005 (sig!)
http://tinyurl.com/d2aho
I saw that too
If you get the original journal you will find two comments on this article
discussing the lack of relation :
1) Testing alone is not enough
2) You must know or learn what to do to improve on the test
3) You must be motivated enough to do so
These factors have not been included in research sofar
For those who like to know , here is a link to a website which has an article
from Diabetes Care, June, 2005 by Mayer B. Davidson .This is a very recent
overview with a lot of references from which you can work you way back in
history:
http://www.zoeticzone.com/p/articles/mi_m0CUH/is_6_28/ai_n14705098?pi=zoe
The original article is :
Counterpoint: self-monitoring of blood glucose in type 2 diabetic patients not
receiving insulin: a waste of money
Diabetes Care, June, 2005 by Mayer B. Davidson.
Quote:
Most people would agree that treatment plans, especially those that have
invasive components and/or are expensive, should result in improved clinical
outcomes. Self-monitoring of blood glucose (SMBG), as part of a treatment plan,
fulfills both of these criteria but does have the potential to improve outcomes
by lowering glycemia and thereby decreasing diabetic retinopathy, nephropathy,
and neuropathy. In insulin-requiring patients, A1C levels are inversely related
to the frequency of SMBG measurements (1-7), attesting to the beneficial effect
of this component of the treatment plan. However, simply measuring blood glucose
is ineffective.
unQuote
Quote:
There are at least three possible explanations for the lack of an effect of SMBG
(Self Monitoring Blood Glucose) in patients. First, patients receive little or
no feedback on their results. Second, related to the first, they are not taught
the self-management skills required to lower the measured glucose values. Third,
in my experience, the vast majority of patients measure their glucose level
either fasting or preprandially, rather than postprandially. Fasting values
serve neither to educate (there is no information on the effect of meal
composition or size) nor to effectively motivate (postprandial values are much
higher).
unQuote
to summarize :
1) Testing alone is not enough
2) You must know or learn what to do to improve on the test
3) You must be motivated enough to do so
These factors have not been included in research sofar
So conflicting results sofar
So no evidence based medicine sofar
Gys
.
- Follow-Ups:
- Re: Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes.
- From: Jenny
- Re: Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes.
- From: palm
- Re: Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes.
- From: palm
- Re: Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes.
- References:
- Prev by Date: Re: Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes.
- Next by Date: Reputable researchers
- Previous by thread: Re: Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes.
- Next by thread: Re: Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes.
- Index(es):
Relevant Pages
|